sulfanilamide has been researched along with Premenstrual Syndrome in 2 studies
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GRASSET, J | 1 |
| GAUTHIER, R | 1 |
| OTTURI, JE | 1 |
2 other studies available for sulfanilamide and Premenstrual Syndrome
| Article | Year |
|---|---|
[Clinical trials of 4-chlorophenyl-1,3-disulfonamide in edemas of pregnancy and the premenstrual syndrome].
Topics: Diuretics; Edema; Edetic Acid; Female; Humans; Pregnancy; Pregnancy Complications; Premenstrual Synd | 1961 |
[Premenstrual tension. Treatment with a new sulfonamide diuretic: cyclopenthiazide].
Topics: Chlorothiazide; Cyclopenthiazide; Diuretics; Female; Humans; Premenstrual Syndrome; Sulfanilamide; S | 1962 |